Alexandra Dambeck has decided to step down from her role as Chief Financial Officer of Springer Nature and as a member of the Management Board to pursue a new external opportunity. Her specific departure date in the fourth quarter of 2026 will be confirmed later, and she will remain in her position until that time. The process of selecting and appointing a successor is already underway.
Frank Vrancken Peeters, CEO of Springer Nature, acknowledged Dambeck's contributions, stating he had very much enjoyed working with her and thanked her for her commitment, professionalism and dedication throughout her tenure. This period included the company's successful initial public offering. He wished her the very best in her future endeavors.
Stefan von Holtzbrinck, Chair of the Supervisory Board, also expressed thanks and gratitude to Dambeck for all she achieved during her time at the publisher. He noted that she leaves the company in a strong financial position and set up for future growth.
The departure of a key financial executive at a major global publisher like Springer Nature carries significant implications for the academic and research publishing industry. As one of the world's leading publishers of research, Springer Nature publishes the largest number of journals and books and is a pioneer in open research. The company provides technology-enabled products, platforms and services that help researchers uncover new ideas, assist health professionals in staying current with medical science, and support educators in advancing learning. For more information, please visit about.springernature.com.
Leadership transitions at this level require careful management to ensure continuity in financial strategy and operations, particularly for a company that plays such a central role in the global research ecosystem. The statement from the Supervisory Board Chair indicating the company is left in a strong financial position suggests the transition is planned and the foundation for stability is in place. The ongoing search for a successor will be closely watched by investors, researchers, and institutional customers who rely on Springer Nature's vast portfolio of publications and services. The company's ability to maintain its financial health and strategic direction during this change will be critical to its continued role in sharing knowledge and bringing greater understanding to the world.
